Call for Papers | Application Process Now Open for 2025 SCI Paper Awards
Release Date:
2025-11-04 15:59
On the journey of exploring life sciences, every breakthrough is worth celebrating, and every bit of support is worthy of gratitude. Hycells has consistently stood by your side, providing high-quality sample services, technical support, and specialized products to empower your research and development efforts. To express our heartfelt appreciation for the trust and support of both new and longstanding customers, Hycells is proudly launching a paper submission reward program—offering exclusive rewards as a token of our gratitude and paying tribute to every researcher!
Event Details
Regardless of which Hycells services or products you have used, as long as you acknowledge Hycells or Hycells in your published paper and submit the required information as outlined below, you will be eligible to receive the exclusive rewards we have carefully prepared just for you!
Eligibility requirements:
- Articles published after January 1, 2025
- The article explicitly acknowledges Hycells or Hycells.
- Have used Hycells’s sample services, technical services, or specialty products
| Impact factor | Reward Details |
IF < 5 | 500 yuan JD gift card |
5 ≤ IF < 10 | 1,000 yuan JD gift card |
10 ≤ IF < 20 | 2,000 yuan JD gift card |
IF≥20 | 5,000 yuan JD gift card |
The article’s impact factor is determined by the impact factor of the year in which the article was publicly published.
Leveraging years of industry expertise, Hycells has established itself as a trusted partner in the life sciences sector. The company’s core competitive advantages are reflected in:
Abundant sample resources: We maintain a valuable biobank that encompasses both Chinese and international populations with health and disease states, supported by a rigorous quality-control system to ensure data accuracy, reliability, and traceability, thereby laying a solid foundation for your research.
Professional technical services: Providing end-to-end solutions spanning experimental design to data analysis to accelerate the R&D process.
A distinctive product portfolio: continuously deepening our expertise in leading technology platforms to drive the R&D and iterative enhancement of specialized products, thereby meeting cutting-edge research needs across multiple domains and at high dimensions.
Event Time
This event is open from today until December 31, 2026, during which period any eligible published articles may participate.
Application Process
Scan the QR code to download the Hycells SCI Paper Reward Application Form. Complete the form and submit it, along with the electronic version of your paper (main text plus SI), to the designated email address. xiezhongming@hys-bio.com Once your application is approved, we will contact you as soon as possible and issue the corresponding reward.
Scan the code to apply
Download the SCI Paper Reward Application Form
Event Information
1. The activity is intended for research institutions or the principal researchers of enterprises;
2. Each article is eligible for only one claim, and only one individual (the first author or the corresponding author) may submit the application; rewards for multiple products and services cannot be combined.
3. If the same author publishes multiple articles using the same product, only the article with the highest impact factor will be counted for participation in the activity.
4. In the paper, correctly cite the name and product/service number of any Hycells products or services used; alternatively, acknowledge “Hycells Biotechnology” or “Shanghai Hycells Biotechnology Co., Ltd.” or “Hycells” in the acknowledgments section.
5. Hycells Biotechnology is permitted to cite article data or images for promotional purposes.
Let us join hands and forge new achievements on the journey of scientific exploration! Hycells looks forward to your participation in writing a new chapter in the life sciences!
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board